HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$99.99
Day range
$100.64 - $106.71
Year range
$11.17 - $106.71
Market cap
1.22B USD
Avg Volume
215.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.18M | 101.05% |
Net income | -11.34M | -67.45% |
Net profit margin | — | — |
Earnings per share | -1.03 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 63.57M | 347.43% |
Total assets | 66.94M | 310.13% |
Total liabilities | 28.26M | -14.69% |
Total equity | 38.68M | — |
Shares outstanding | 11.84M | — |
Price to book | 28.65 | — |
Return on assets | -36.17% | — |
Return on capital | -43.49% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.34M | -67.45% |
Cash from operations | -7.88M | -187.31% |
Cash from investing | — | — |
Cash from financing | 242.00K | -89.97% |
Net change in cash | -6.87M | -1,980.61% |
Free cash flow | -4.87M | -170.07% |
About
Website
Employees
14
